ENG
Vertigo Treatment Market Size, Share, Growth Trends, Industry Analysis, Key Players, Investment Opportunities and Forecast (2025-2032)
Vertigo Treatment Market size was valued at USD 1.77 Bn in 2024 and the total Vertigo Treatment Market revenue is expected to grow at a CAGR of 5.23 % from 2025 to 2032, reaching nearly USD 2.66 Bn by 2032.
Format : PDF | Report ID : SMR_2681
Vertigo Treatment Market Overview
Vertigo (spinning dizziness) is a symptom caused by the effects of a variety of underlying vestibular system disorders, as the benign paroxysmal positional vertigo (BPPV), Meniere’s disease, and vestibular neuritis.
Expansion of the worldwide vertigo treatment market is due to rise in vertigo in adults and old age people, growth in geriatric population, enhancement in ear disorders awareness and treatment. Cheap drugs and easy availability of OTC drugs are some of the other drivers for the market. Efforts and product launches of both the government and private companies are also expected to fuel the market growth. Growing number of clearances and product launches by key market players reflect growth prospects for the vertigo treatment market during the forecast period.
An Irish Medtech startup, Vertigenius, has created a revolutionary approach for the treatment of vertigo. With the Medzorb wearable head sensor and companion smartphone app, the company has developed a clearMX to enable clinicians to remotely prescribe, monitor and track vestibular rehabilitation exercises. Patients can use this technology at home to do exercises with the close supervision and accountability of a therapist. In May 2024, Vertigenius raised more than €2.1 million in seed funding from Atlantic Bridge, Ascentifi, and Enterprise Ireland. The investment helped accelerate the company’s growth, as it looks to enter the UK and US markets, and the development of a second-generation head sensor which is slated to launch in 2025.
To get more Insights: Request Free Sample Report
Vertigo Treatment Market Dynamics
Growing prevalence of vertigo to drive vertigo treatment market
Rising prevalence of vertigo and vestibular disorders worldwide is one of the main factors contributing to the growth of vertigo treatment market. An estimated 35% of adults 40 years or older in the US approximately 69 million Americans have experienced vestibular dysfunction according to Vestibular Disorders Association [VeDA], 2010. The prevalence of vertigo also increases with age and it is reported that up to 50% of subjects older than 85 years have dizziness and balance disturbances which potentially could result in falling and loss of quality of life.
Limited Awareness and Misdiagnosis of Vertigo Conditions to Restrain the Vertigo Treatment Market
Untreated vertigo, along with lack of patient education, actively works against the vertigo treatment market because it creates a lack of awareness to both the patients and the primary care physician level, hence leading to misdiagnosis. Some of vertigo’s symptoms are often related to other medical troubles such as anxiety or even migraines which can set back the treatment process. This slows down patients care while simultaneously creating a stagnant demand for focused therapies which, in turn, limits market advancement and development in specialized vertigo healthcare.
Growing Geriatric Population to Boost Vertigo Treatment Market
The increasing older population around the world offers a remarkable chance in the vertigo treatment market as older individuals tend to suffer from balance and vestibular system disorders. More aged people suffering from vertigo increases the need for focused therapies available to these patients which gives and drives specialist healthcare and pharmaceutical companies to develop and diversify their services for better assistive care.
Vertigo Treatment Market Segment Analysis
Based on type, the market is segmented into peripheral vertigo and central vertigo. The peripheral vertigo section was the highest revenue contributor in the market in 2024, and is expected to continue this trend during the forecast period, which is due to an increase in the spread of benign paroxysmal positional vertigo. On the other hand, the central vertigo segment is expected to see a significant increase in the size of the vertigo treatment market during the forecast period, due to the increase in problems of the brain stem and cerebellum between adults.
Based on treatment type, the market is segmented into medications, surgery and others. Medications accounted for the highest market share of the global vertigo treatment market. A lot of people choose medicine over other types of treatment because it is often completed quickly. The global proliferation of vertigo medication and drug varieties is contributing to the growth of the market. Medication for vertigo also aid in treating patients' nausea and dizziness, which are side effects of vertigo.
Based on end user, the market is segmented into hospitals, clinics and others. Hospitals ruled the vertigo treatment market in 2024 because of their advanced diagnostic infrastructure, availability of specialized healthcare professionals, and capability to provide comprehensive treatment options together with remedy, vestibular rehabilitation, and surgical interventions. Hospitals are the number one desire for patients with moderate to severe vertigo, specially among the developing aged populace, that's more susceptible to vestibular disorders.
Vertigo Treatment Market Regional Analysis
North America
This accounts for a dominant share of the global vertigo treatment market. The surging occurrence of vertigo in the getting older populace of this region is the high aspect driving vertigo treatment market. The presence of key pharmaceutical agencies on this area has additionally contributed to the high availability of different vertigo tablets and remedies. The United States and Canada forecasted to grow to be the leading markets in this place for vertigo treatment. Women in this region are greater prone to stricken by vertigo compared to guys. Growing investments in scientific studies and authorities support for the same are also predicted to foster innovation in the vertigo treatment marketplace.
Vertigo Treatment Market Competitive landscape
- April 16, 2024, Amneal Pharmaceuticals, Inc. announced the launch of PEMRYDI RTU®, the first and only ready-to-use presentation of pemetrexed for injection. This product does not require reconstitution, dilution, or refrigeration, which is different than other versions of pemetrexed for injection.
- April 22, 2024, Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections because of aerobic Gram-negative organisms in adult patients with limited treatment options.
- On May 20, 2024, ANI Pharmaceuticals, Inc. announced the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS® Suspension for Oral or Rectal use.
Vertigo Treatment Market Scope table
|
Vertigo Treatment Market Scope |
||
|
Market Size in 2024 |
USD 1.77 Bn. |
|
|
Market Size in 2032 |
USD 2.66 Bn. |
|
|
CAGR (2025-2032) |
5.23 % |
|
|
Historic Data |
2019-2024 |
|
|
Base Year |
2024 |
|
|
Forecast Period |
2025-2032 |
|
|
Segments Analysis |
By Type Peripheral Vertigo Central Vertigo |
|
|
By Treatment Type Medications Surgery Others |
||
|
By End User Hospitals Clinics Others |
||
|
Regional Scope |
North America: United States, Canada, Mexico Europe: United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, Rest of Europe Asia Pacific (APAC): China, Japan, South Korea, India, Australia, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Rest of APAC Middle East & Africa (MEA): South Africa, GCC, Nigeria, Egypt, Turkey, Rest of MEA South America: Brazil, Argentina, Colombia, Chile, Peru, Rest of South America |
|
Key Players of Vertigo Treatment Market
North America
- AdvaCare Pharma (United States)
- WellSpring Pharmaceutical Corporation (United States)
- Mylan N.V. (United States)
- Amneal Pharmaceuticals LLC (United States)
- Prestige Consumer Healthcare Inc. (United States)
- Casper Pharma (United States)
- Epic Pharma, LLC (United States)
- Sagent Pharmaceuticals (United States)
- Pfizer Inc. (United States)
- ANI Pharmaceuticals (United States)
- Endo Pharmaceuticals Inc (United States)
- Viatris Inc. (United States)
- Sound Pharmaceuticals (United States)
Europe
- Hoffmann-La Roche (Switzerland)
- Medichem S.A. (Spain)
- Sanofi (France)
- GlaxoSmithKline (United Kingdom)
Asia Pacific
- Zydus Cadila (India)
- Sun Pharmaceutical Industries Ltd (India)
- Intas Pharmaceutical Ltd. (India)
Middle East and Africa
- Emirates Hospitals Group (UAE)
- Aspen Pharmacare (South Africa)
- Dr. Sam’s Clinic (UAE)
- American Hospital Dubai (UAE)
- LGM Pharma (South Africa)
- Saudi German Hospitals (UAE)
- Mueller Medical Clinic (UAE)
South America
- Eurofarma Laboratórios S.A. (Brazil)
- EMS Farmacêutica Ltda. (Brazil)
- União Química Farmacêutica Nacional S.A. (Brazil)
- CFR Pharmaceuticals S.A. (Chile)
- Laboratorios Farmindustria S.A. (Peru)
Frequently Asked Questions
North America has expected to lead in the global vertigo treatment market.
The Global Vertigo treatment market size was USD 1.77 Bn in 2024.
The segments covered in the vertigo treatment market are by type, by treatment type and by end user.
The top companies to hold the market share in the vertigo treatment market are AdvaCare Pharma, Wellspring Pharmaceutical Corporation, Mylan N.V., Amneal Pharmaceuticals LLC and Prestige Consumer Healthcare Inc.
1. Vertigo Treatment Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Vertigo Treatment Market: Competitive Landscape
2.1. SMR Competition Matrix
2.2. Key Players Benchmarking
2.2.1. Company Name
2.2.2. Service Segment
2.2.3. End-User Segment
2.2.4. Revenue (2024)
2.2.5. Geographical Presence
2.3. Market Structure
2.3.1. Market Leaders
2.3.2. Market Followers
2.3.3. Emerging Players
2.4. Mergers and Acquisitions Details
3. Vertigo Treatment Market: Dynamics
3.1. Vertigo Treatment Market Trends
3.2. Vertigo Treatment Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Regulatory Landscape by Region
3.6. Key Opinion Leader Analysis for the Global Industry
3.7. Analysis of Government Schemes and Initiatives for Industry
4. Vertigo Treatment Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
4.1. Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
4.1.1. Peripheral Vertigo
4.1.2. Central Vertigo
4.2. Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
4.2.1. Medications
4.2.2. Surgery
4.2.3. Others
4.3. Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
4.3.1. Hospitals
4.3.2. Clinics
4.3.3. Others
4.4. Vertigo Treatment Market Size and Forecast, By Region (2024-2032)
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. Middle East and Africa
4.4.5. South America
5. North America Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
5.1. North America Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
5.1.1. Peripheral Vertigo
5.1.2. Central Vertigo
5.2. North America Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
5.2.1. Medications
5.2.2. Surgery
5.2.3. Others
5.3. North America Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Others
5.4. North America Vertigo Treatment Market Size and Forecast, by Country (2024-2032)
5.4.1. United States
5.4.1.1. United States Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
5.4.1.1.1. Peripheral Vertigo
5.4.1.1.2. Central Vertigo
5.4.1.2. United States Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
5.4.1.2.1. Medications
5.4.1.2.2. Surgery
5.4.1.2.3. Others
5.4.1.3. United States Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
5.4.1.3.1. Hospitals
5.4.1.3.2. Clinics
5.4.1.3.3. Others
5.4.2. Canada
5.4.2.1. Canada Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
5.4.2.1.1. Peripheral Vertigo
5.4.2.1.2. Central Vertigo
5.4.2.2. Canada Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
5.4.2.2.1. Medications
5.4.2.2.2. Surgery
5.4.2.2.3. Others
5.4.2.3. Canada Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
5.4.2.3.1. Hospitals
5.4.2.3.2. Clinics
5.4.2.3.3. Others
5.4.3. Mexico
5.4.3.1. Mexico Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
5.4.3.1.1. Peripheral Vertigo
5.4.3.1.2. Central Vertigo
5.4.3.2. Mexico Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
5.4.3.2.1. Medications
5.4.3.2.2. Surgery
5.4.3.2.3. Others
5.4.3.3. Mexico Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
5.4.3.3.1. Hospitals
5.4.3.3.2. Clinics
5.4.3.3.3. Others
6. Europe Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
6.1. Europe Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.2. Europe Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.3. Europe Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4. Europe Vertigo Treatment Market Size and Forecast, by Country (2024-2032)
6.4.1. United Kingdom
6.4.1.1. United Kingdom Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.1.2. United Kingdom Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.1.3. United Kingdom Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.2. France
6.4.2.1. France Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.2.2. France Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.2.3. France Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.3. Germany
6.4.3.1. Germany Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.3.2. Germany Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.3.3. Germany Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.4. Italy
6.4.4.1. Italy Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.4.2. Italy Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.4.3. Italy Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.5. Spain
6.4.5.1. Spain Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.5.2. Spain Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.5.3. Spain Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.6. Sweden
6.4.6.1. Sweden Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.6.2. Sweden Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.6.3. Sweden Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.7. Russia
6.4.7.1. Russia Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.7.2. Russia Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.7.3. Russia Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
6.4.8.2. Rest of Europe Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
6.4.8.3. Rest of Europe Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7. Asia Pacific Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
7.1. Asia Pacific Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.2. Asia Pacific Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.3. Asia Pacific Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4. Asia Pacific Vertigo Treatment Market Size and Forecast, by Country (2024-2032)
7.4.1. China
7.4.1.1. China Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.1.2. China Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.1.3. China Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.2. S Korea
7.4.2.1. S Korea Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.2.2. S Korea Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.2.3. S Korea Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.3. Japan
7.4.3.1. Japan Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.3.2. Japan Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.3.3. Japan Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.4. India
7.4.4.1. India Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.4.2. India Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.4.3. India Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.5. Australia
7.4.5.1. Australia Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.5.2. Australia Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.5.3. Australia Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.6. Indonesia
7.4.6.1. Indonesia Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.6.2. Indonesia Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.6.3. Indonesia Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.7. Malaysia
7.4.7.1. Malaysia Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.7.2. Malaysia Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.7.3. Malaysia Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.8. Philippines
7.4.8.1. Philippines Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.8.2. Philippines Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.8.3. Philippines Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.9. Thailand
7.4.9.1. Thailand Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.9.2. Thailand Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.9.3. Thailand Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.10. Vietnam
7.4.10.1. Vietnam Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.10.2. Vietnam Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.10.3. Vietnam Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
7.4.11. Rest of Asia Pacific
7.4.11.1. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
7.4.11.2. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
7.4.11.3. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8. Middle East and Africa Vertigo Treatment Market Size and Forecast (by Value in USD Billion) (2024-2032)
8.1. Middle East and Africa Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.2. Middle East and Africa Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.3. Middle East and Africa Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8.4. Middle East and Africa Vertigo Treatment Market Size and Forecast, by Country (2024-2032)
8.4.1. South Africa
8.4.1.1. South Africa Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.4.1.2. South Africa Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.4.1.3. South Africa Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8.4.2. GCC
8.4.2.1. GCC Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.4.2.2. GCC Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.4.2.3. GCC Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8.4.3. Egypt
8.4.3.1. Egypt Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.4.3.2. Egypt Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.4.3.3. Egypt Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8.4.4. Nigeria
8.4.4.1. Nigeria Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.4.4.2. Nigeria Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.4.4.3. Nigeria Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
8.4.5. Rest of ME&A
8.4.5.1. Rest of ME&A Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
8.4.5.2. Rest of ME&A Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
8.4.5.3. Rest of ME&A Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9. South America Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032)
9.1. South America Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.2. South America Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.3. South America Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9.4. South America Vertigo Treatment Market Size and Forecast, by Country (2024-2032)
9.4.1. Brazil
9.4.1.1. Brazil Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.4.1.2. Brazil Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.4.1.3. Brazil Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9.4.2. Argentina
9.4.2.1. Argentina Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.4.2.2. Argentina Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.4.2.3. Argentina Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9.4.3. Colombia
9.4.3.1. Colombia Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.4.3.2. Colombia Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.4.3.3. Colombia Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9.4.4. Chile
9.4.4.1. Chile Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.4.4.2. Chile Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.4.4.3. Chile Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
9.4.5. Rest Of South America
9.4.5.1. Rest Of South America Vertigo Treatment Market Size and Forecast, By Type (2024-2032)
9.4.5.2. Rest Of South America Vertigo Treatment Market Size and Forecast, By Treatment Type (2024-2032)
9.4.5.3. Rest Of South America Vertigo Treatment Market Size and Forecast, By End-User (2024-2032)
10. Company Profile: Key Players
10.1. Advacare Pharma
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Recent Developments
10.2. WellSpring Pharmaceutical Corporation
10.3. Mylan N.V.
10.4. Amneal Pharmaceuticals LLC
10.5. Prestige Consumer Healthcare Inc.
10.6. Casper Pharma
10.7. Epic Pharma, LLC
10.8. Sagent Pharmaceuticals
10.9. Pfizer Inc.
10.10. ANI Pharmaceuticals
10.11. Endo Pharmaceuticals Inc
10.12. Viatris Inc.
10.13. Sound Pharmaceuticals
10.14. Hoffmann-La Roche
10.15. Medichem S.A.
10.16. Sanofi
10.17. GlaxoSmithKline
10.18. Zydus Cadila
10.19. Sun Pharmaceutical Industries Ltd
10.20. Intas Pharmaceutical Ltd.
10.21. Emirates Hospitals Group
10.22. Aspen Pharmacare
10.23. Dr. Sam’s Clinic
10.24. American Hospital Dubai
10.25. LGM Pharma
10.26. Saudi German Hospitals
10.27. Mueller Medical Clinic
10.28. Eurofarma Laboratórios S.A.
10.29. EMS Farmacêutica Ltda.
10.30. União Química Farmacêutica Nacional S.A.
10.31. CFR Pharmaceuticals S.A.
10.32. Laboratorios Farmindustria S.A.
11. Key Findings
12. Industry Recommendations
13. Vertigo Treatment Market: Research Methodology
